Research is the backbone of progress in oncology, and at the OncoEval Pioneers Group, we are fully committed to pushing the boundaries of what is possible. Our research spans across various subfields, including molecular oncology, clinical trials, and population health studies. By integrating both clinical and laboratory research approaches, we aim to develop new insights that challenge existing paradigms and lead to more effective treatments and diagnostic methods. Our research methodology is grounded in a multi-disciplinary approach, leveraging the latest technologies in genomics, proteomics, and bioinformatics, alongside traditional clinical practices. This combination allows us to address complex research questions with precision and innovation. Furthermore, we engage in collaborative research with other leading institutions worldwide, fostering a network of expertise that enriches our studies and expands the impact of our findings. Our research portfolio includes both investigator-initiated projects and large-scale collaborative studies, designed to generate high-quality, actionable knowledge. By contributing to international conferences and publishing in high-impact journals, we ensure our work not only advances the field but also reaches a global audience, influencing oncology practices worldwide.